monoclonal or polyclonal antibody or antigen-binding fragment thereof, polynucleotide, monoclonal antibody, vector, hybridoma, antibody, hybridoma 5166-2 and / or 5166-9, antigen-binding antibody or fragment, pharmaceutical composition, antibody use or antibody binding fragment, method for treating cancer, method for diagnosing cancer in an individual, antibody, method, composition or use

摘要

abstract monoclonal or polyclonal antibody or antigen-binding fragment thereof, polynucleotide, monoclonal antibody, vector, hybridoma, antibody, hybridoma 5166-2 and / or 5166-9, antigen-binding antibody or fragment, pharmaceutical composition, use of the Antibody or Antibody Binding Fragment, Method for Treating Cancer, Method for Diagnosing Cancer in an Individual, Antibody, Method, Composition or Use This invention relates to c1orf32 specific antibodies, antibody fragments, alternative platforms, conjugates and compositions which understand them for cancer treatment. 1/1